Watch APTN. Know when insiders buy.
One email the day a filing lands. Free.
APTN
ADAPTIN BIO, INC.
6.27
+0.00 +0.00%
USD · close Aug 19
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $57.9MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$5.4MNET CASH —52W 5.60 – 6.27SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$1.2M | −$1.2M | — | -0.14 | −$450K | — | — | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$1.1M | −$1.1M | — | 0.13 | −$596K | — | — | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$1.4M | −$1.4M | — | -0.16 | −$703K | — | — | Apr 1 |
| Q3 2025 · Sep 30 | — | — | — | −$1.7M | −$1.7M | — | -0.20 | −$772K | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$1.5M | −$1.5M | — | -0.18 | −$1M | — | — | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$850K | −$603K | — | 0.10 | −$2.3M | — | — | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$508K | −$857K | — | -0.26 | $113K | — | — | Apr 1 |
| Q3 2024 · Sep 30 | — | — | — | −$995K | −$1.1M | — | -0.34 | −$468K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$767K | −$819K | — | -0.25 | −$204K | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$300K | −$339K | — | -0.10 | −$90K | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | −$34K | −$34K | — | -0.01 | −$58K | — | — | Apr 15 |
| Q3 2023 · Sep 30 | — | — | — | −$43K | −$43K | — | -0.01 | — | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$5.4M | −$5.2M | — | -0.66 | −$4.8M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$2.6M | −$3.1M | — | -0.96 | −$649K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$86K | −$86K | — | -0.02 | −$81K | — | — | — | — |
Every number comes from ADAPTIN BIO, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.